Ranitidine bismuth citrate with clarithromycin for the eradication of Helicobacter pylori and for ulcer healing

Helicobacter

Volumn 2, Issue 3, 1997, Pages 132-139

  Pounder, Roy E ^a   Wyeth, John W ^a   Duggan, Annette E ^b   Bailey, Robert J ^c   Louw, Japie A ^d   Ohlin, Bo ^e  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ROYAL ALEXANDRA HOSPITAL   (Canada)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e Centralsjukhuset   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIULCER AGENT; BISMUTH CITRATE; CLARITHROMYCIN; ORGANOMETALLIC COMPOUND; RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DUODENUM ULCER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RANITIDINE; TREATMENT OUTCOME;

EID: 0031217091     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1997.tb00074.x     Document Type: Article

References (9)

1. Dixon JS. Helicobacter pylori eradication: Unravelling the facts. Scand J Gastroenterol 1995;30 (suppl 212):48-62.
2. McColm AA, McLaren A, Klinkert G, et al. Ranitidine bismuth citrate: A novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrateranitidine admixture. Aliment Pharmacol Ther 1996;10:241-50.
3. Stables R, Campbell CJ, Clayton NM, et al. Gas-tric antisecretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bis-muth citrate. Aliment Pharmacol Ther 1993;7:237-46.
4. Prewett EJ, Nwokolo CN, Hudson M, Sawyerr AM, Fraser A, Pounder RE. The effect of GR122311X, a bismuth compound with H2-antagonist activity on 24-hour intragastric acidity. Aliment Pharmacol Ther 1991;5:481-90.
5. Bardhan KD, Dekkers CPM, Lam SK, et al. GR122311X (ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Aliment Pharmacol Ther 1995;9:497-506.
6. Bailey RJ, Marliez K, Rosch W, et al. GR122311X (ranitidine bismuth citrate) a new drug for the treatment of gastric ulcer [abstract]. Gastroenterology 1995;108:A51.
7. Wyeth JW, Pounder RE, Duggan AE, et al. Safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996;10:623-30.
8. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double-blind trial. Am J Gastroenterol 1993;88:1860-4.
9. McLaren A, McDowell SR, Bagshaw JA, McColm AA. The synergistic interaction between GR122311X and clarithromycin against Helicobacter [abstract]. Am J Gastroenterol 1994;89:1382.